IONETIX has rethought and re-engineered the delivery model for N-13 Ammonia, making it affordable and achievable for practices of all sizes.
Through our N-13 Ammonia as a service solution, we build, operate and promote revenue-generating cardiac PET programs using N-13 Ammonia as a tracer. The result is brand-differentiating cardiac PET programs with ZERO capital outlay for health systems, hospitals, and cardiology and radiology practice groups.
Through a unique service model incorporating our compact cyclotron, IONETIX eliminates the exorbitant capital expenditure typically associated with launching a new service line.
IONETIX covers all capital costs associated with the cyclotron. This includes construction, installation, and even staffing required to manage and operate the cyclotron. You pay only for your doses of N-13 Ammonia.
From the moment you say "yes" to N-13 Ammonia as a service, IONETIX steps in to handle the installation, launch, and management of your N-13 Ammonia dose supply. We bring our experience and expertise to every project to ensure it is installed and operated safely and meets with FDA approval.
Our Turnkey solution includes:
The backbone of the IONETIX N-13 Ammonia as a service solution is a superconducting compact cyclotron.
Featuring a patent-protected design based on superconducting magnets, the ION-12SC compact cyclotron has a substantially smaller footprint than traditional cyclotrons making installation on or near medical campuses more achievable than ever before.
Capable of producing as many doses of N-13 Ammonia as needed, the compact cyclotron ensures a consistent and reliable radiopharmaceutical at the point-of-care and provides you with complete control of patient testing schedules.